title: Lack of negative interaction between use of β-blockers and statins on cardiovascular outcomes among patients with or at risk for atherothrombosis.
authors.affiliation: Département Hospitalo-Universitaire Fibrosis-Inflammation-REmodelling: Hôpital Bichat (Assistance Publique-Hôpitaux de Paris), and INSERM U-1148, Université Paris-Diderot, Paris, France.
authors.forename: Jérémie
authors.initials: J
authors.lastname: Abtan
authors.affiliation: Département Hospitalo-Universitaire Fibrosis-Inflammation-REmodelling: Hôpital Bichat (Assistance Publique-Hôpitaux de Paris), and INSERM U-1148, Université Paris-Diderot, Paris, France.
authors.forename: Yedid
authors.initials: Y
authors.lastname: Elbez
authors.affiliation: Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
authors.forename: Deepak L
authors.initials: DL
authors.lastname: Bhatt
authors.affiliation: Département Hospitalo-Universitaire Fibrosis-Inflammation-REmodelling: Hôpital Bichat (Assistance Publique-Hôpitaux de Paris), and INSERM U-1148, Université Paris-Diderot, Paris, France; National Heart and Lung Institute, Institute of Cardiovascular Medicine and Science, Royal Brompton Hospital, Imperial College, London, United Kingdom. Electronic address: gabriel.steg@bch.aphp.fr.
authors.forename: Philippe Gabriel
authors.initials: PG
authors.lastname: Steg
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D000368:Aged; D050197:Atherosclerosis / Q000517:prevention & control*; D004347:Drug Interactions; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D008875:Middle Aged; D012042:Registries; D013927:Thrombosis / Q000517:prevention & control*
chemical_list: D000319:Adrenergic beta-Antagonists; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors